Sign in
Active, not recruitingNo phase

Gracie Diet for Gastroesophageal Reflux Disease

Key facts

Who runs it
Johns Hopkins University
Where
Baltimore, United StatesSee the site
Trial code
Status
Active, not recruiting
People taking part
30 people, planned
Started
13 Nov 2020
Expected to end
Dec 2027
Type of study
Interventional
Treatments tested
  • Gracie Diet
Record updated
16 January 2026

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Age 18 years or older at registration
  • Patients with ongoing symptoms of GERD: heartburn (pyrosis) mid-sternal chest pain, regurgitation of fluid or food, development of esophageal inflammation that may lead to swallowing dysfunction, or extraesophageal manifestations (i.e. cough, bronchospasms, and hoarseness)
  • Use of one of the following PPI medications: omeprazole, lansoprazole, pantoprazole, rabeprazole, esomeprazole or dexlansoprazole. And/or use of one of the following H2 blockers medications as well: famotidine, cimetidine, ranitidine or nizatidine
  • Willing to comply with the Gracie diet regimen

Who cannot take part

  • A prior surgery of the upper gastrointestinal tract
  • Complicated oropharyngeal dysphagia or other condition with risk for aspiration from oral ingestion
  • Exclusion of other causes of symptoms as mechanical gastrointestinal obstruction, Barrett's esophagus and cancer of the esophagus by standard radiographic or endoscopic test evidenced in the medical record chart
  • Failure to give informed consent
  • Any other condition, which in the opinion of the investigator would impede compliance or hinder the completion of the study
  • Age < than 18 years
  • Patients unable to speak English
  • Pregnancy or nursing

Where in United States

  • Johns Hopkins Bayview Medical CenterBaltimore, United States

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn if dietary changes can help improve gastroesophageal reflux disease (GERD) symptoms. The main question[s] it aims to answer whether the Gracie Diet is an option to treat GERD symptoms in individuals wish to discontinue standard doses of PPI and / or H2 receptor antagonists.

Read full original descriptionShow less

Participants will be taken off PPI and be placed on the Gracie Diet for 8 weeks. Information about the participants reflux symptoms and GERD health related quality of life will be collected to assess the effect of the diet.

The group in the trial

  • Gracie DietTreatment being tested

    Patients will have a nutritional consultation and will follow the Gracie diet for a month.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
16 January 2026